321 related articles for article (PubMed ID: 26437030)
1. DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control.
Kretzmer H; Bernhart SH; Wang W; Haake A; Weniger MA; Bergmann AK; Betts MJ; Carrillo-de-Santa-Pau E; Doose G; Gutwein J; Richter J; Hovestadt V; Huang B; Rico D; Jühling F; Kolarova J; Lu Q; Otto C; Wagener R; Arnolds J; Burkhardt B; Claviez A; Drexler HG; Eberth S; Eils R; Flicek P; Haas S; Humme M; Karsch D; Kerstens HHD; Klapper W; Kreuz M; Lawerenz C; Lenzek D; Loeffler M; López C; MacLeod RAF; Martens JHA; Kulis M; Martín-Subero JI; Möller P; Nage I; Picelli S; Vater I; Rohde M; Rosenstiel P; Rosolowski M; Russell RB; Schilhabel M; Schlesner M; Stadler PF; Szczepanowski M; Trümper L; Stunnenberg HG; Küppers R; Ammerpohl O; Lichter P; Siebert R; Hoffmann S; Radlwimmer B
Nat Genet; 2015 Nov; 47(11):1316-1325. PubMed ID: 26437030
[TBL] [Abstract][Full Text] [Related]
2. Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.
Aukema SM; Kreuz M; Kohler CW; Rosolowski M; Hasenclever D; Hummel M; Küppers R; Lenze D; Ott G; Pott C; Richter J; Rosenwald A; Szczepanowski M; Schwaenen C; Stein H; Trautmann H; Wessendorf S; Trümper L; Loeffler M; Spang R; Kluin PM; Klapper W; Siebert R;
Haematologica; 2014 Apr; 99(4):726-35. PubMed ID: 24179151
[TBL] [Abstract][Full Text] [Related]
3. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ
Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575
[TBL] [Abstract][Full Text] [Related]
4. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing.
Richter J; Schlesner M; Hoffmann S; Kreuz M; Leich E; Burkhardt B; Rosolowski M; Ammerpohl O; Wagener R; Bernhart SH; Lenze D; Szczepanowski M; Paulsen M; Lipinski S; Russell RB; Adam-Klages S; Apic G; Claviez A; Hasenclever D; Hovestadt V; Hornig N; Korbel JO; Kube D; Langenberger D; Lawerenz C; Lisfeld J; Meyer K; Picelli S; Pischimarov J; Radlwimmer B; Rausch T; Rohde M; Schilhabel M; Scholtysik R; Spang R; Trautmann H; Zenz T; Borkhardt A; Drexler HG; Möller P; MacLeod RA; Pott C; Schreiber S; Trümper L; Loeffler M; Stadler PF; Lichter P; Eils R; Küppers R; Hummel M; Klapper W; Rosenstiel P; Rosenwald A; Brors B; Siebert R;
Nat Genet; 2012 Dec; 44(12):1316-20. PubMed ID: 23143595
[TBL] [Abstract][Full Text] [Related]
5. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
[TBL] [Abstract][Full Text] [Related]
6. Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis.
Hezaveh K; Kloetgen A; Bernhart SH; Mahapatra KD; Lenze D; Richter J; Haake A; Bergmann AK; Brors B; Burkhardt B; Claviez A; Drexler HG; Eils R; Haas S; Hoffmann S; Karsch D; Klapper W; Kleinheinz K; Korbel J; Kretzmer H; Kreuz M; Küppers R; Lawerenz C; Leich E; Loeffler M; Mantovani-Loeffler L; López C; McHardy AC; Möller P; Rohde M; Rosenstiel P; Rosenwald A; Schilhabel M; Schlesner M; Scholz I; Stadler PF; Stilgenbauer S; Sungalee S; Szczepanowski M; Trümper L; Weniger MA; Siebert R; Borkhardt A; Hummel M; Hoell JI;
Haematologica; 2016 Nov; 101(11):1380-1389. PubMed ID: 27390358
[TBL] [Abstract][Full Text] [Related]
7. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R
Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752
[TBL] [Abstract][Full Text] [Related]
8. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
McClure RF; Remstein ED; Macon WR; Dewald GW; Habermann TM; Hoering A; Kurtin PJ
Am J Surg Pathol; 2005 Dec; 29(12):1652-60. PubMed ID: 16327438
[TBL] [Abstract][Full Text] [Related]
9. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma.
López C; Kleinheinz K; Aukema SM; Rohde M; Bernhart SH; Hübschmann D; Wagener R; Toprak UH; Raimondi F; Kreuz M; Waszak SM; Huang Z; Sieverling L; Paramasivam N; Seufert J; Sungalee S; Russell RB; Bausinger J; Kretzmer H; Ammerpohl O; Bergmann AK; Binder H; Borkhardt A; Brors B; Claviez A; Doose G; Feuerbach L; Haake A; Hansmann ML; Hoell J; Hummel M; Korbel JO; Lawerenz C; Lenze D; Radlwimmer B; Richter J; Rosenstiel P; Rosenwald A; Schilhabel MB; Stein H; Stilgenbauer S; Stadler PF; Szczepanowski M; Weniger MA; Zapatka M; Eils R; Lichter P; Loeffler M; Möller P; Trümper L; Klapper W; ; Hoffmann S; Küppers R; Burkhardt B; Schlesner M; Siebert R
Nat Commun; 2019 Mar; 10(1):1459. PubMed ID: 30926794
[TBL] [Abstract][Full Text] [Related]
10. Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas.
Seegmiller AC; Garcia R; Huang R; Maleki A; Karandikar NJ; Chen W
Mod Pathol; 2010 Jul; 23(7):909-20. PubMed ID: 20348878
[TBL] [Abstract][Full Text] [Related]
11. Concurrent development of "Burkitt-like" lymphoma and BCL-2-rearranged low-grade B cell lymphoma sharing the same germinal center origin.
Kobayashi H; Ichikawa M; Hangaishi A; Imai Y; Kurokawa M
Int J Hematol; 2011 Jan; 93(1):112-7. PubMed ID: 21184290
[TBL] [Abstract][Full Text] [Related]
12. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
13. Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas.
Aggarwal N; Swerdlow SH; Kelly LM; Ogilvie JB; Nikiforova MN; Sathanoori M; Nikiforov YE
Mod Pathol; 2012 Sep; 25(9):1203-11. PubMed ID: 22575864
[TBL] [Abstract][Full Text] [Related]
14. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
Bouska A; Bi C; Lone W; Zhang W; Kedwaii A; Heavican T; Lachel CM; Yu J; Ferro R; Eldorghamy N; Greiner TC; Vose J; Weisenburger DD; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; Siebert R; Miles RR; Dave S; Reddy A; Delabie J; Staudt LM; Song JY; McKeithan TW; Fu K; Green M; Chan WC; Iqbal J
Blood; 2017 Oct; 130(16):1819-1831. PubMed ID: 28801451
[TBL] [Abstract][Full Text] [Related]
15. The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas.
Rodig SJ; Kutok JL; Paterson JC; Nitta H; Zhang W; Chapuy B; Tumwine LK; Montes-Moreno S; Agostinelli C; Johnson NA; Ben-Neriah S; Farinha P; Shipp MA; Piris MA; Grogan TM; Pileri SA; Gascoyne RD; Marafioti T
Haematologica; 2010 Dec; 95(12):2056-62. PubMed ID: 20823132
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
Miyaoka M; Kikuti YY; Carreras J; Ikoma H; Hiraiwa S; Ichiki A; Kojima M; Ando K; Yokose T; Sakai R; Hoshikawa M; Tomita N; Miura I; Takata K; Yoshino T; Takizawa J; Bea S; Campo E; Nakamura N
Mod Pathol; 2018 Feb; 31(2):313-326. PubMed ID: 28984304
[TBL] [Abstract][Full Text] [Related]
17. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.
Johnson NA; Savage KJ; Ludkovski O; Ben-Neriah S; Woods R; Steidl C; Dyer MJ; Siebert R; Kuruvilla J; Klasa R; Connors JM; Gascoyne RD; Horsman DE
Blood; 2009 Sep; 114(11):2273-9. PubMed ID: 19597184
[TBL] [Abstract][Full Text] [Related]
18. Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma.
Gualco G; Queiroga EM; Weiss LM; Klumb CE; Harrington WJ; Bacchi CE
Hum Pathol; 2009 Apr; 40(4):565-71. PubMed ID: 19144381
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis.
Mossafa H; Damotte D; Jenabian A; Delarue R; Vincenneau A; Amouroux I; Jeandel R; Khoury E; Martelli JM; Samson T; Tapia S; Flandrin G; Troussard X
Leuk Lymphoma; 2006 Sep; 47(9):1885-93. PubMed ID: 17065002
[TBL] [Abstract][Full Text] [Related]
20. MYC rearranged B-cell neoplasms: Impact of genetics on classification.
Haberl S; Haferlach T; Stengel A; Jeromin S; Kern W; Haferlach C
Cancer Genet; 2016 Oct; 209(10):431-439. PubMed ID: 27810071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
